πŸ‡ΊπŸ‡Έ FDA
Patent

US 12162864

Condensed-cyclic compound

granted A61KA61K9/0019A61K9/0053

Quick answer

US patent 12162864 (Condensed-cyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K9/0019, A61K9/0053, A61K9/2018, A61K9/2059